Mingjuan Liao on Muck Rack

Mingjuan Liao

As seen in: Nature, The BMJ
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mingjuan

Contact Mingjuan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Bufalin targets E2F2 to transcriptionally inhibit LINC01410 and suppress Wnt/β-catenin signaling in esophageal squamous cell carcinoma

|
By Yufei Ma, Hongke Zhao, Haoling Zhang, Mingjuan Liao, Ying Wei, Xingqiao Li, Yueyang Zhou, Xiaoxia Yan, Wangzheqi Zhang, Yadong Guo, Fei Cao, Tingmin Chang, Xiaohong Kang, Mridul Roy, Huange Xue
| Nature
Abstract Bufalin, a main active monomer component extracted from the Traditional Chinese Medicine toad venom, exhibits potent anti-tumour activity across diverse malignancies. However, its specific molecular targets in Oesophageal squamous cell carcinoma (ESCC) remain unclear. Here, we demonstrate that bufalin suppresses ESCC growth and metastasis in a concentration-dependent manner both in vitro and in vivo.
Open in Who Shared Issue with article?

Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis

|
By Byun J-Y, Zidong Ma, Fei Cao, Mingjuan Liao
| The BMJ
Abstract Objective To evaluate the risk of cardiovascular adverse events associated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer (NSCLC). Design Systematic review and network meta-analysis. Data sources PubMed, Embase, Web of Science, Scopus, Cochrane Central Register of Controlled Trials, and three clinical trial registries, from inception to 20 November 2024.
Open in Who Shared Issue with article?
See all 2 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Mingjuan

Contact Mingjuan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified